Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.

Explaining Chagas disease through the stories of patients in Latin America.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Researchers around the world are collaborating to provide solutions to immediate and future challenges.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.